ArticleAntibody therapeutics2024

ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks.

Mohamed A Alfaleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.